ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

tert-Butyl piperazine-1-carboxylate → tert-butyl 4-(1H-indol-7-yl)piperazine-1-carboxylate

HRID 563
印刷

反応式

HRID 563 の反応式
Brc1cccc2cc[nH]c12.CC(C)(C)OC(=O)N1CCNCC1>CC(=O)O.CC(=O)O.CC(C)(C)[O-].CC(C)Oc1cccc(OC(C)C)c1-c1ccccc1P(C1CCCCC1)C1CCCCC1.Cc1ccccc1.[Na+].[Pd]>CC(C)(C)OC(=O)N1CCN(c2cccc3cc[nH]c23)CC1
参加物反応条件実験手順出典と根拠反応ノート

参加物

7

反応物 2

HCID 143452tert-Butyl piperazine-1-carboxylateHCID 27570207-Bromoindole

生成物 1

HCID 21070951tert-butyl 4-(1H-indol-7-yl)piperazine-1-carboxylate収率 0%

試薬・触媒・溶媒 4

HCID 23676156Sodium t-butoxide試薬HCID 4144353Palladium (II) acetate触媒
HCID 16217985
2-Dicyclohexylphosphino-2',6'-diisopropoxybiphenyl
触媒
HCID 1140Toluene溶媒

反応条件

温度
100 °C

実験手順

2-Dicyclohexylphosphino-2',6'-di-i-propoxy-1,1'-biphenyl (75 mg, 0.16 mmol) and palladium (II) acetate (18.08 mg, 0.08 mmol) were dissoved in toluene (2 mL) at ambient temperature. The mixture was degassed and purged with nitrogen and warmed to 50°C for 20 mins. In a separate vessel, were mixed tert-butyl piperazine-1-carboxylate (300 mg, 1.61 mmol), 7-bromo-1H-indole (316 mg, 1.61 mmol) and sodium-t-butoxide (296 mL, 2.42 mmol) in toluene (3 mL). The mixture was degasssed and purged with nitrogen and warmed to 50°C. The catalyst solution was added to the reaction vessel and the resulting mixture was degassed and purged with nitrogen and heated at 100°C for overnight. UPLC analysis showed virtually no reaction (only 7% conversion to product). Reaction abandoned.

出典と根拠

ORDレコード
ord-b6527d32ba054a8395bc5ea7808e53a8
出典データセット
750 AstraZeneca ELN dataset
元リンク
出典を表示

反応ノート

このページの内容参加物反応条件実験手順出典と根拠反応ノート